About Everolimus
            
            Class: | Antineoplastic agent, mTOR inhibitor  
Use: | Indicated for the prevention of organ rejection in kidney transplant patients and for the treatment of certain types of advanced cancers, including neuroendocrine tumors and breast cancer.  
Adult dose: | Typically, 0.75 mg to 1.5 mg once daily, adjusted based on clinical response and tolerability.  
Pediatric dose: | Not established; use in pediatric patients should be based on clinical judgment and careful monitoring.  
Side effects: | Com
         
        
            
                
                
                    
                        Drug Class
                    
                    Antineoplastic agent, mTOR inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Indicated for the prevention of organ rejection in kidney transplant patients and for the treatment of certain types of advanced cancers, including neuroendocrine tumors and breast cancer.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20°C to 25°C or 68°F to 77°F) in a tightly closed container, protected from moisture and light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Novartis Pharma AG, SWITZERLAND
                    
                    
                    Package Size
                    60's (10's Blister x 6)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 338.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Typically, 0.75 mg to 1.5 mg once daily, adjusted based on clinical response and tolerability.
                    
                    
                        Pediatric Dose
                    
                    
                        Not established; use in pediatric patients should be based on clinical judgment and careful monitoring.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include mouth ulcers, diarrhea, nausea, fatigue, rash, and increased risk of infections.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to everolimus or any component of the formulation; concurrent use with strong CYP3A4 inhibitors or inducers; pregnancy and breastfeeding.
         
        
        
            
                Important Warnings
            
            Increased risk of infections, potential for renal impairment, and risk of malignancies; monitor for signs of rejection in transplant patients; avoid live vaccines during treatment.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.